Cyndeo Wealth Partners Boosts Stake in Johnson & Johnson

Investment firm increases holding in pharmaceutical giant by 25.2% in Q4 2025

Mar. 24, 2026 at 7:52am

Got story updates? Submit your updates here. ›

Cyndeo Wealth Partners LLC increased its stake in shares of Johnson & Johnson (NYSE:JNJ) by 25.2% in the fourth quarter of 2025, according to a recent disclosure with the Securities & Exchange Commission. The firm now owns 130,031 shares of the company's stock, worth approximately $26.91 million.

Why it matters

Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a strong presence in pharmaceuticals, medical devices, and consumer products. Institutional investors closely monitor changes in ownership of the company's stock, as it can signal broader market sentiment and investment trends.

The details

Cyndeo Wealth Partners increased its position in Johnson & Johnson by purchasing an additional 26,199 shares during the fourth quarter. The firm's total investment in the company is now valued at $26,910,000, making it the 9th largest holding in Cyndeo's investment portfolio.

  • Cyndeo Wealth Partners increased its stake in Q4 2025.

The players

Cyndeo Wealth Partners LLC

An investment management firm that oversees a portfolio of stocks, bonds, and other assets for its clients.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

The increased investment by Cyndeo Wealth Partners in Johnson & Johnson reflects the firm's confidence in the company's long-term growth prospects and ability to weather market volatility. As a major player in the healthcare industry, changes in Johnson & Johnson's ownership structure are closely watched by investors and analysts.